Correlation Between Compania Cervecerias and Aquestive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Compania Cervecerias and Aquestive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Compania Cervecerias and Aquestive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Compania Cervecerias Unidas and Aquestive Therapeutics, you can compare the effects of market volatilities on Compania Cervecerias and Aquestive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Compania Cervecerias with a short position of Aquestive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Compania Cervecerias and Aquestive Therapeutics.
Diversification Opportunities for Compania Cervecerias and Aquestive Therapeutics
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Compania and Aquestive is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Compania Cervecerias Unidas and Aquestive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquestive Therapeutics and Compania Cervecerias is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Compania Cervecerias Unidas are associated (or correlated) with Aquestive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquestive Therapeutics has no effect on the direction of Compania Cervecerias i.e., Compania Cervecerias and Aquestive Therapeutics go up and down completely randomly.
Pair Corralation between Compania Cervecerias and Aquestive Therapeutics
Considering the 90-day investment horizon Compania Cervecerias Unidas is expected to generate 0.29 times more return on investment than Aquestive Therapeutics. However, Compania Cervecerias Unidas is 3.47 times less risky than Aquestive Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Aquestive Therapeutics is currently generating about -0.25 per unit of risk. If you would invest 1,167 in Compania Cervecerias Unidas on October 21, 2024 and sell it today you would lose (1.00) from holding Compania Cervecerias Unidas or give up 0.09% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Compania Cervecerias Unidas vs. Aquestive Therapeutics
Performance |
| Timeline |
| Compania Cervecerias |
| Aquestive Therapeutics |
Compania Cervecerias and Aquestive Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Compania Cervecerias and Aquestive Therapeutics
The main advantage of trading using opposite Compania Cervecerias and Aquestive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Compania Cervecerias position performs unexpectedly, Aquestive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquestive Therapeutics will offset losses from the drop in Aquestive Therapeutics' long position.| Compania Cervecerias vs. Boston Beer | Compania Cervecerias vs. Molson Coors Beverage | Compania Cervecerias vs. Ambev SA ADR | Compania Cervecerias vs. Molson Coors Brewing |
| Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Dynavax Technologies | Aquestive Therapeutics vs. Amphastar P | Aquestive Therapeutics vs. Lantheus Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |